Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HRDetect in Tubo-ovarian Carcinoma: Stratification and Therapeutic Implications.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Interest in Genetic Testing for Hereditary Cancer Risk: Associations with Genetic Familiarity, Self-Efficacy, and Sociodemographics.

Public health genomics·2026
Same author

Radial Access in Interventional Radiology and the Risk of Stroke: Lessons Learned.

Journal of vascular and interventional radiology : JVIR·2026
Same author

Dynamic Monitoring of Recurrent Ovarian Cancer Using Serial ctDNA: A Real-World Case Series.

Current oncology (Toronto, Ont.)·2025
Same author

Nivolumab and Ipilimumab for Metastatic Castration-Resistant Prostate Cancer With an Immunogenic Signature: The Multicenter, Two-Cohort, Phase II NEPTUNES Study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025
Same author

Long-read DNA and RNA sequencing for inherited polyposis and colorectal cancer: cryptic intronic variants and multiple mutational mechanisms.

Journal of medical genetics·2025

Related Experiment Video

Updated: Jul 12, 2025

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

11.9K

Adoption of Universal Testing in Endometrial Cancers for Microsatellite Instability Using Next-Generation Sequencing.

Isabel V Rodriguez1, Sarah Strickland2, David Wells3

  • 1Department of Obstetrics and Gynecology, University of Washington, Seattle, WA.

JCO Precision Oncology
|October 19, 2023
PubMed
Summary

Next-generation sequencing (NGS) effectively screens for Lynch syndrome (LS) and identifies endometrial cancer (EC) molecular subtypes. This approach improves follow-up testing rates compared to traditional methods.

More Related Videos

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing
11:11

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing

Published on: August 24, 2017

16.9K
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.4K

Related Experiment Videos

Last Updated: Jul 12, 2025

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

11.9K
Detection of Rare Mutations in CtDNA Using Next Generation Sequencing
11:11

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing

Published on: August 24, 2017

16.9K
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.4K

Area of Science:

  • Oncology
  • Genetics
  • Molecular Diagnostics

Background:

  • Endometrial cancer (EC) management benefits from molecular subtyping.
  • Lynch syndrome (LS) screening is crucial for hereditary cancer risk assessment.
  • Next-generation sequencing (NGS) offers advanced molecular profiling capabilities.

Purpose of the Study:

  • To evaluate the implementation of an NGS assay for microsatellite instability (MSI) detection in EC.
  • To utilize MSI results for Lynch syndrome (LS) screening.
  • To characterize and compare the four molecular subtypes of EC.

Main Methods:

  • Retrospective review of 408 newly diagnosed EC patients.
  • Comparison of 140 patients screened with NGS versus 268 screened with mismatch repair immunohistochemistry (MMR IHC).
  • Classification of EC into molecular subtypes: POLE-ultramutated, MSI-high (MSI-H), TP53-mutated, and no specific molecular profile (NSMP).

Main Results:

  • NGS identified MSI-H EC in 27% of cases, with 1% diagnosed with LS.
  • Molecular subtypes included POLE-ultramutated (n=8), TP53-mutated (n=28), and NSMP (n=66).
  • MSI-H and TP53-mutated EC exhibited poorer prognostic features; NGS increased follow-up testing by 56% vs 89% (P=.001).

Conclusions:

  • NGS enables simultaneous MSI screening for LS and molecular subtyping of EC.
  • Molecular subtypes identified by NGS have significant prognostic and therapeutic implications.
  • NGS implementation enhances diagnostic efficiency and patient management for EC.